# Black Diamond Therapeutics, Inc.: Form 8-K, filed Jun 22, 2021

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: 8-K
- Filed: 2021-06-22
- Accepted by EDGAR: Jun 22, 2021, 16:12 ET
- Period: 2021-06-18
- Accession: 0001104659-21-084116
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000110465921084116/tm2120388d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000110465921084116/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000110465921084116/tm2120388d1_8k.htm

Filed Jun 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-084116. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.
